Laxxon Medical’s Post

View organization page for Laxxon Medical, graphic

2,203 followers

What’s the secret to achieving a 10-fold increase in GLP-1 agonist bioavailability in our LXM.2 oral solid tablet?   The addition of a permeation enhancer (PE) to the formulation improves active pharmaceutical ingredient (API) absorption by reducing tight junctions in the duodenum, enabling the API to pass through the intestinal barrier into the bloodstream. However, PEs are known for local and gastrointestinal irritation. We lowered the total dose of PE by utilizing our novel Multi-compartment Microtablet design. Learn more about our innovative products enabled by our powerful manufacturing capabilities in our webinar with CEO Helmut Kerschbaumer: https://lnkd.in/eW2VCJ3m #DrugDevelopment #GLP1 #Agonist #Obesity #InnovateWithUs #SmartDrugDelivery #LXM2 #PermeationEnhancer #SPIDTechnology #LaxxonMedical

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics